- High gross margin of 81.8%
- Beat earnings estimates in 3 of the last 4 quarters
- Strong operating margin of 45.3%
Stronger technical forecast for Novo Nordisk A/S stock price after Tuesday trading
(Updated on Jun 23, 2026)
The Novo Nordisk A/S stock price gained 1.62% on the last trading day (Tuesday, 23rd Jun 2026), rising from $46.09 to $46.84. During the last trading day the stock fluctuated 7.49% from a day low at $44.32 to a day high of $47.64. The price has risen in 7 of the last 10 days and is up by 13.55% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 4 thousand more shares were traded than the day before. In total, 4 thousand shares were bought and sold for approximately $203.80 thousand.
The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 23.94% during the next 3 months and, with a 90% probability hold a price between $53.08 and $62.68 at the end of this 3-month period.
NONOF Signals & Forecast
Mostly positive signals in the chart today. The Novo Nordisk A/S stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $44.62 and $44.33. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday, June 08, 2026, and so far it has risen 13.55%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Novo Nordisk A/S has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk.
Support, Risk & Stop-loss for Novo Nordisk A/S stock
On the downside, the stock finds support just below today's level from accumulated volume at $38.82 and $35.80. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Novo Nordisk A/S finds support just below today's level at $38.82. If this is broken, then the next support from accumulated volume will be at $35.80 and $35.58.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $3.32 between high and low, or 7.49%. For the last week, the stock has had daily average volatility of 6.36%.
Our recommended stop-loss: $45.06 (-3.80%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 10 days ago.)
Trading Expectations (NONOF) For The Upcoming Trading Day Of Wednesday 24th
For the upcoming trading day on Wednesday, 24th we expect Novo Nordisk A/S to open at $46.27, and during the day (based on 14 day Average True Range), to move between $45.59 and $48.09, which gives a possible trading interval of +/-$2.50 (+/-5.48%) up or down from last closing price. If Novo Nordisk A/S takes out the full calculated possible swing range there will be an estimated 5.48% move between the lowest and the highest trading price during the day.
With no resistance above and support from accumulated volume @ $38.82, some $8.02 (17.13%) from the current price of $46.84, our system finds the risk reward attractive.
Is Novo Nordisk A/S stock A Buy?
Novo Nordisk A/S holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months. We have upgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Strong Buy candidate.
Current score:
5.159
Strong Buy Candidate
Upgraded
Predicted Fair Opening Price
Predicted fair opening price on June 24, 2026 - $46.27 ( 1.22%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
NONOF Performance
Trading levels for NONOF
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 49.59 | 5.87% |
| R2 | 48.32 | 3.16% |
| R1 | 47.53 | 1.49% |
| Price | 46.84 | |
| S1 | 45.00 | -3.93% |
| S2 | 44.21 | -5.60% |
| S3 | 42.95 | -8.31% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0 | - |
| R2 | 0 | - |
| R1 | 0 | - |
| Price | 46.84 | |
| S1 | 38.82 | -17.13% |
| S2 | 35.80 | -23.56% |
| S3 | 35.58 | -24.04% |
NONOF Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Feb 04, 2026 | Mar 30, 2026 | Mar 31, 2026 | $1.25 | 2.57% |
| 2 | Mar 27, 2026 | Mar 27, 2026 | Mar 31, 2026 | $1.25 | 2.81% |
| 3 | Aug 06, 2025 | Aug 18, 2025 | Aug 19, 2025 | $0.586 | 1.07% |
| 4 | Aug 15, 2025 | Aug 15, 2025 | Aug 19, 2025 | $0.585 | 1.15% |
| 5 | Feb 05, 2024 | Mar 31, 2025 | Apr 01, 2025 | $1.14 | 1.69% |
FAQ
Click here for our free guide on how to buy Novo Nordisk A/S Stock.
Buy NONOF